Form 4: Surgery Partners' Chief Strategy Officer Sells Shares to Cover Tax Obligations

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., sold 3,156 shares of common stock on March 10, 2025, to satisfy tax withholding obligations related to vesting restricted stock.

Summary

• On March 10, 2025, Marissa Brittenham, the Chief Strategy Officer of Surgery Partners, Inc., sold 3,156 shares of the company's common stock.
• The sale was executed at a weighted average price of $24.09 per share.
• This transaction was to cover tax withholding obligations related to the vesting of restricted stock on February 28, 2025, and March 2, 2025.
• Following the transaction, Brittenham directly owns 63,408 shares of Surgery Partners, Inc.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale to cover tax obligations, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to the market.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the stock price given the reason for the sale.

Key Dates